Trial · NCT01218308
Results by group200
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 200
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects Reporting at Least One Confirmed Occurrence of Influenza A or B. | FluLaval® Quadrivalent Group | 58 | subjects | ||
| Number of Subjects Reporting at Least One Confirmed Occurrence of Influenza A or B. | Havrix Group | 128 | subjects | ||
| Number of Subjects Reporting at Least One Moderate to Severe Occurrence of Influenza A or B. | FluLaval® Quadrivalent Group | 14 | subjects | ||
| Number of Subjects Reporting at Least One Moderate to Severe Occurrence of Influenza A or B. | Havrix Group | 52 | subjects | ||
| Number of Subjects Reporting at Least One Culture Confirmed Occurrence of Influenza A or B Due to Antigenically Matched Strain. | FluLaval® Quadrivalent Group | 31 | subjects | ||
| Number of Subjects Reporting at Least One Culture Confirmed Occurrence of Influenza A or B Due to Antigenically Matched Strain. | Havrix Group | 56 | subjects | ||
| Number of Subjects Reporting at Least One Culture Confirmed Occurrence of Influenza A or B Due to Any Strain. | FluLaval® Quadrivalent Group | 50 | subjects | ||
| Number of Subjects Reporting at Least One Culture Confirmed Occurrence of Influenza A or B Due to Any Strain. | Havrix Group | 112 | subjects | ||
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | FluLaval® Quadrivalent Group | H1N1, PRE [N=457;117] | 15.3 | 95% Confidence Interval 13.6 to 17.3 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | Havrix Group | H1N1, PRE [N=457;117] | 16.1 | 95% Confidence Interval 12.6 to 20.5 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | FluLaval® Quadrivalent Group | H1N1, POST [N=457;121] | 318.8 | 95% Confidence Interval 291.0 to 349.2 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | Havrix Group | H1N1, POST [N=457;121] | 16.1 | 95% Confidence Interval 12.8 to 20.2 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | FluLaval® Quadrivalent Group | H3N2, PRE [N=457;117] | 24.3 | 95% Confidence Interval 21.9 to 27.0 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | Havrix Group | H3N2, PRE [N=457;117] | 28.6 | 95% Confidence Interval 23.5 to 34.8 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | FluLaval® Quadrivalent Group | H3N2, POST [N=457;122] | 264.7 | 95% Confidence Interval 244.3 to 286.8 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | Havrix Group | H3N2, POST [N=457;122] | 30.3 | 95% Confidence Interval 24.8 to 36.9 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | FluLaval® Quadrivalent Group | Victoria, PRE [N=457;117] | 13.7 | 95% Confidence Interval 12.2 to 15.4 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | Havrix Group | Victoria, PRE [N=457;117] | 15.6 | 95% Confidence Interval 12.2 to 20.1 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | FluLaval® Quadrivalent Group | Victoria, POST [N=457;120] | 239.9 | 95% Confidence Interval 214.6 to 268.2 | titers |
| Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 4 Strains of Influenza Disease. | Havrix Group | Victoria, POST [N=457;120] | 17.8 | 95% Confidence Interval 13.7 to 23.1 | titers |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01218308/results